Clinical trials
Completed trials in Jordan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
417 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 8 |
| 2008 | 8 |
| 2009 | 12 |
| 2010 | 5 |
| 2011 | 4 |
| 2012 | 12 |
| 2013 | 7 |
| 2014 | 23 |
| 2015 | 10 |
| 2016 | 18 |
| 2017 | 30 |
| 2018 | 29 |
| 2019 | 35 |
| 2020 | 38 |
| 2021 | 38 |
| 2022 | 35 |
| 2023 | 28 |
| 2024 | 26 |
| 2025 | 26 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 417 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Jordan | 74 |
| Jordan University of Science and Technology | 51 |
| King Abdullah University Hospital | 22 |
| Novartis Pharmaceuticals | 20 |
| Applied Science Private University | 14 |
| Bayer | 13 |
| Al-Zaytoonah University of Jordan | 11 |
| Humanis Saglık Anonim Sirketi | 11 |
| Jordan Collaborating Cardiology Group | 8 |
| Pfizer | 8 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 18 |
| Diabetes Mellitus, Type 2 | 16 |
| Pain | 15 |
| Breast Neoplasms | 14 |
| Hypertension | 12 |
| Multiple Sclerosis | 11 |
| COVID-19 | 9 |
| Insulin Resistance | 9 |
| Anxiety Disorders | 8 |
| Vitamin D Deficiency | 8 |
Trials
Showing 1 to 25 of 417. Each trial links to its page on Pharma Observatory.
317 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.